Target intelligence / Profile preview

Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1)

Target
IGHV7-4-1
Molecular classification
Immunoglobulin variable region, Other (immunoglobulin gene segment, not a standalone receptor, enzyme, transporter, etc.)
01

Overview

Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1) is a gene segment encoding a variable region of the immunoglobulin heavy chain, which is part of the antigen-binding site in human antibodies[1]. It participates in generating the diverse repertoire of antibodies produced by B lymphocytes through somatic recombination (V-(D)-J rearrangement), which is essential for the adaptive immune system’s ability to recognize a wide range of antigens[1][2]. IGHV7-4-1 is expressed at low levels compared to other immunoglobulin heavy variable genes and may have reduced capacity to produce functional products due to an unusual cysteine residue at position 92, potentially compromising the structure or stability of antibodies derived from this segment[2]. This gene is not a receptor, enzyme, or typical therapeutic target by itself, but rather a genetic element contributing to antibody diversity[1][2].

Other names
Immunoglobulin heavy variable-74-1IGHVII-74-1IGHV(II)-74-1
02

Biological functions

Antigen bindingImmune response (specifically, immunoglobulin-mediated immunity)
03

Disease associations

Other (no direct standalone disease association; may contribute to antibody diversity and thus influence immune response against infection, autoimmune disease, or cancer indirectly, but not as a single therapeutic target)
04

Safety considerations

Not applicable; this is a gene segment, not a drug target

Beyond the preview

Go deeper on Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 7-4-1 (IGHV7-4-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call